16.80p+10.55 (+168.80%)03 Jul 2024, 17:19
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Crism Therapeutics Corporation Fundamentals

Company NameCrism Therapeutics CorporationLast Updated2024-07-03
IndustryOther Industrial Metals & MiningSectorBasic Materials
Shares in Issue32.678 mMarket Cap£5.49 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-$1.10EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.1605Cash Equity Ratio1.0630
Quick Ratio6.6224Current Ratio7.23
Price To Book Value0.6262ROCE0

Crism Therapeutics Corporation Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Crism Therapeutics Corporation Company Financials

Assets202320222021
Tangible Assets000
Intangible Assets000
Investments000
Total Fixed Assets0$25.20 m$24.45 m
Stocks000
Debtors00-$9,000.00
Cash & Equivalents$4.38 m$3.48 m$6.68 m
Other Assets000
Total Assets$4.79 m$28.74 m$31.24 m
Liabilities202320222021
Creditors within 1 year$662,000.00$745,000.00$1.13 m
Creditors after 1 year0$176,000.000
Other Liabilities00$159,000.00
Total Liabilities$662,000.00$921,000.00$1.13 m
Net assets$4.12 m$27.82 m$30.11 m
Equity202320222021
Called up share capital$80.79 m$80.79 m$80.45 m
Share Premium$4.28 m$4.28 m$4.28 m
Profit / Loss-$2.39 m-$2.60 m-$1.79 m
Other Equity$4.12 m$27.82 m$30.11 m
Preference & Minorities000
Total Capital Employed$4.12 m$27.82 m$30.11 m
Ratios202320222021
Debt Ratio000
Debt-to-Equity000
Assets / Equity1.16051.16051.1605
Cash / Equity1.06301.06301.0630
EPS-$0.27-$0.26-$0.21
Cash Flow202320222021
Cash from operating activities000
Cashflow before financing000
Increase in Cash$714,000.00-$3.06 m$4.21 m
Income202320222021
Turnover000
Cost of sales000
Gross Profit000
Operating Profit-$2.26 m-$2.60 m-$1.79 m
Pre-Tax profit-$2.39 m-$2.60 m-$1.79 m

Crism Therapeutics Corporation Company Background

SectorBasic Materials
ActivitiesCrism Therapeutics Corp formerly Amur Minerals Corp is a cash shell company.
Latest Interim Date25 Sep 2023
Latest Fiscal Year End Date10 May 2024

Crism Therapeutics Corporation Directors

AppointedNamePosition
2011-08-09Mr. George William O'Neale EcclesNon-Executive Director
2024-05-29Mr. Thomas Edward Bowens Non-Executive Director
2009-12-31Mr. William Philip McLucasNon-Executive Director
2009-12-31Mr. Eric David McAuslanNon-Executive Director
2021-06-30Mr. Brian Charles SavageNon-Executive Director
2024-05-29Mr. Robert William SchaferNon-Executive Director,Chairman
2024-05-29Mr. Robin Jay Young BScExecutive Director,Chief Executive Officer
2011-10-03Mr. David Fain Wood BA,MBAChief Financial Officer & Co Secretary
2011-08-09Mr. David Straker-SmithNon-Executive Director
2024-05-29Mr. Paul Terence GazzardNon-Executive Director
2020-05-20Mr. Ljupco Lou NaumovskiNon-Executive Director
2021-06-30Mr. Adam HabibExecutive Director,President
2024-06-03Mr. Gerald Douglas BeaneyNon-Executive Director
2024-05-31Mr. Andrew James WebbExecutive Director,Chief Executive Officer
2024-05-31Dr. Christopher McConvilleExecutive Director,Chief Scientific Officer

Crism Therapeutics Corporation Contact Details

Company NameCrism Therapeutics Corp
AddressKingston Chambers, P.O. Box 173, Tortola, Road Town, null
Telephone
Websitehttps://www.amurminerals.com

Crism Therapeutics Corporation Advisors

SolicitorNorton Rose Fulbright (Central Europe) LLP
Phone+7 4999245101
Nominated AdviserSP Angel
Phone+44 2034700470
Fax+44 2076291341
Financial AdviserSP Angel
Phone+44 2034700470
Fax+44 2076291341
StockbrokerSP Angel
Phone+44 2034700470
Fax+44 2076291341
Financial PR AdviserYellow Jersey PR Ltd
SolicitorFieldfisher
Phone+44 2078614000
RegistrarCapita Asset Services
Phone+44 8704027573
Nominated AdviserRBC Capital Markets
Phone020 7653 4000
Fax020 7029 7900
AuditorBDO LLP
Phone+44 2074865888
Fax+44 2074873686
StockbrokerRBC Capital Markets
Phone(020) 7653 4000
Fax(020) 7029 7900
Financial PR AdviserTavistock Communications Ltd
Phone+44 2079203150
Fax+44 2079203151
SolicitorMaples and Calder